|
Journey Medical Corp (NASDAQ: DERM) |
|
Journey Medical Corp
DERM's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Journey Medical's sales fell
by -57.64 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 3460
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Journey Medical faced net loss in contrast to the net income a year ago in III. Quarter 2024
• More on DERM's Growth
|
|
Journey Medical realized a net loss in trailing twelve months.
Journey Medical realized cash reduction of $ -0.11 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.81.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.
• More on DERM's Valuation
|
|
|
|
|
Journey Medical realized net loss in trailing twelve months.
Journey Medical realized cash outflow of $ -0.11per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.81.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.
Journey Medical Price to Book Ratio is at 9.57 lower than Industry Avg. of 82.31. and higher than S&P 500 Avg. of 0.02
• More on DERM's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com